Cervical cancer trials in United Kingdom
12 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Edinburgh, London, Truro, Withington
- Age
- 18 years and over
- People
- 1,023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Oxford, Sutton
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Cambridge, Coventry, London, Nottingham
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleHTL0039732 in Participants With Advanced Solid Tumours
- Where
- Cambridge, Cardiff, Dundee, Liverpool, London, Manchester
- Age
- 18 years and over
- People
- 150
- Run by
- Cancer Research UK
See details and how to joinNCT05944237 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Cambridge, Glasgow, Manchester
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Birmingham, London, Sutton
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleHPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks
- Where
- Edinburgh
- Age
- 25 years to 45 years
- People
- 500
- Run by
- University of Edinburgh
See details and how to joinNCT06414057 - Phase 1/2Taking peopleA Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- Where
- London, Manchester, Newcastle upon Tyne, Southampton
- Age
- 18 years and over
- People
- 167
- Run by
- Cancer Research UK
See details and how to joinNCT06380816 - Phase 1Taking peopleA Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
- Where
- Manchester
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Kortuc, Inc.
See details and how to joinNCT05570422 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Cambridge, Glasgow, London, Manchester, Newcastle, Oxford, Sutton
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - No phaseNot yet taking people in United KingdomEQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults
- Where
- Glasgow, Leeds, Sunderland
- Age
- 25 years to 74 years
- People
- 300
- Run by
- University of Sunderland
See details and how to joinNCT06981182